Preliminary data from the phase I/II study of TP-3654, an oral PIM-1 kinase inhibitor, in patients with myelofibrosis Meeting Abstract


Authors: El Chaer, F.; Yuda, J.; Mccloskey, J.; Rein, L.; Brown, R.; Green, S.; Pu, J.; Shirane, S.; Shimoda, K.; Ichii, M.; Scandura, J.; Kabir, S.; Foulks, J. M.; Mei, J.; Yang, H.; Wade, M.; Stapinski, C.; Lebedinsky, C.; Rampal, R. K.
Abstract Title: Preliminary data from the phase I/II study of TP-3654, an oral PIM-1 kinase inhibitor, in patients with myelofibrosis
Meeting Title: 2023 Japanese Society of Medical Oncology (JSMO)
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 3
Meeting Dates: 2023 Mar 16-18
Meeting Location: Fukuoka, Japan
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-11-01
Start Page: S1427
Language: English
ACCESSION: WOS:001106690100252
DOI: 10.1016/j.annonc.2023.09.278
PROVIDER: wos
Notes: Meeting Abstract: MO50-3 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Raajit Kumar Rampal
    346 Rampal